Reid J. Leonard
Net worth: 882 958 $ as of 2024-03-30
Profile
Reid J.
Leonard served as the Chief Operating Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, he worked as a Venture Partner at MPM BioImpact, Inc. from 2016 to 2017.
Currently, he holds the position of Chief Operating Officer at Werewolf Therapeutics, Inc. since 2019.
Dr. Leonard completed his undergraduate degree at Brandeis University and obtained a doctorate from Purdue University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-01-02 | 136,259 ( 0.32% ) | 882 958 $ | 2024-03-30 |
Former positions of Reid J. Leonard
| Companies | Position | End |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Chief Operating Officer | 2023-06-30 |
Potenza Therapeutics, Inc.
 Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Chief Operating Officer | 2018-11-30 |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Corporate Officer/Principal | 2017-08-31 |
Training of Reid J. Leonard
| Brandeis University | Undergraduate Degree |
| Purdue University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| WEREWOLF THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
- Stock Market
- Insiders
- Reid J. Leonard
